Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 191-200 of 287 for Lung cancer

Edit search filters
  1. Study Of Two Doses Of MK-3475 (Pembrolizumab) Versus Docetaxel In Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)

    Rochester, MN

  2. A Study To Evaluate Biomarker/ALK Inhibitor Combinations In Treating Patients With Stage IV ALK Positive Non-squamous Non-small Cell Lung Cancer (The NCI-NRG ALK Protocol)

    Rochester, MN

  3. A Study To Investigate Ubamatamab With And Without REGN7075 In Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

    Jacksonville, FL, Rochester, MN

  4. A Study Of Atezolizumab Plus Carboplatin And Etoposide With Or Without Tiragolumab In Patients With Untreated Extensive-Stage Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study Of The Safety And Effectiveness Of Atezolizumab Combined With Etoposide, And Carboplatin For Patients With Untreated Extensive-Stage Small Cell Lung Cancer

    Rochester, MN

  6. APL-101 Study Of Subjects With NSCLC With C-Met EXON 14 Skip Mutations And C-Met Dysregulation Advanced Solid Tumors (SPARTA)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Trametinib, Combination Chemotherapy, And Radiation Therapy In Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery

    Rochester, MN

  8. Dose Escalation And Double-blind Study Of Veliparib In Combination With Carboplatin And Etoposide In Treatment-naive Extensive Stage Disease Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  9. A Study Comparing Tarlatamab, Durvalumab, Carboplatin, And Etoposide Versus Durvalumab, Carboplatin, And Etoposide In First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

    Rochester, MN

  10. Durvalumab And Tremelimumab With Or Without High Or Low-Dose Radiation Therapy In Treating Patients With Metastatic Colorectal Or Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer